These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 38797703)
1. Redox Properties of Mn(III)porphyrins in Hyaluronan Oxidative Degradation: Single Electron Transfer Mechanism. Valachová K; Moura NMM; Šoltés L Chemistry; 2024 Jul; 30(42):e202401028. PubMed ID: 38797703 [TBL] [Abstract][Full Text] [Related]
2. Ortho Isomeric Mn(III) N-Alkyl- and Alkoxyalkylpyridylporphyrins-Enhancers of Hyaluronan Degradation Induced by Ascorbate and Cupric Ions. Valachová K; Rapta P; Moura NMM; Batinic-Haberle I; Šoltés L Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445313 [TBL] [Abstract][Full Text] [Related]
3. Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins. Tovmasyan AG; Rajic Z; Spasojevic I; Reboucas JS; Chen X; Salvemini D; Sheng H; Warner DS; Benov L; Batinic-Haberle I Dalton Trans; 2011 Apr; 40(16):4111-21. PubMed ID: 21384047 [TBL] [Abstract][Full Text] [Related]
4. Redox modulation of oxidative stress by Mn porphyrin-based therapeutics: the effect of charge distribution. Rebouças JS; Spasojević I; Tjahjono DH; Richaud A; Méndez F; Benov L; Batinić-Haberle I Dalton Trans; 2008 Mar; (9):1233-42. PubMed ID: 18283384 [TBL] [Abstract][Full Text] [Related]
5. Quality of potent Mn porphyrin-based SOD mimics and peroxynitrite scavengers for pre-clinical mechanistic/therapeutic purposes. Rebouças JS; Spasojević I; Batinić-Haberle I J Pharm Biomed Anal; 2008 Nov; 48(3):1046-9. PubMed ID: 18804338 [TBL] [Abstract][Full Text] [Related]
6. Anticancer therapeutic potential of Mn porphyrin/ascorbate system. Tovmasyan A; Sampaio RS; Boss MK; Bueno-Janice JC; Bader BH; Thomas M; Reboucas JS; Orr M; Chandler JD; Go YM; Jones DP; Venkatraman TN; Haberle S; Kyui N; Lascola CD; Dewhirst MW; Spasojevic I; Benov L; Batinic-Haberle I Free Radic Biol Med; 2015 Dec; 89():1231-47. PubMed ID: 26496207 [TBL] [Abstract][Full Text] [Related]
7. Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum. Archambeau JO; Tovmasyan A; Pearlstein RD; Crapo JD; Batinic-Haberle I Redox Biol; 2013; 1(1):599-607. PubMed ID: 24363995 [TBL] [Abstract][Full Text] [Related]
8. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+). Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z Redox Biol; 2014; 2():400-10. PubMed ID: 24624330 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+. Weitner T; Kos I; Sheng H; Tovmasyan A; Reboucas JS; Fan P; Warner DS; Vujaskovic Z; Batinic-Haberle I; Spasojevic I Free Radic Biol Med; 2013 May; 58():73-80. PubMed ID: 23328731 [TBL] [Abstract][Full Text] [Related]
10. Rational design of superoxide dismutase (SOD) mimics: the evaluation of the therapeutic potential of new cationic Mn porphyrins with linear and cyclic substituents. Tovmasyan A; Carballal S; Ghazaryan R; Melikyan L; Weitner T; Maia CG; Reboucas JS; Radi R; Spasojevic I; Benov L; Batinic-Haberle I Inorg Chem; 2014 Nov; 53(21):11467-83. PubMed ID: 25333724 [TBL] [Abstract][Full Text] [Related]
11. Lipophilicity of potent porphyrin-based antioxidants: comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins. Kos I; Rebouças JS; DeFreitas-Silva G; Salvemini D; Vujaskovic Z; Dewhirst MW; Spasojević I; Batinić-Haberle I Free Radic Biol Med; 2009 Jul; 47(1):72-8. PubMed ID: 19361553 [TBL] [Abstract][Full Text] [Related]
12. Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells. Jaramillo MC; Briehl MM; Batinic-Haberle I; Tome ME Free Radic Biol Med; 2015 Jun; 83():89-100. PubMed ID: 25725417 [TBL] [Abstract][Full Text] [Related]
13. A comprehensive evaluation of catalase-like activity of different classes of redox-active therapeutics. Tovmasyan A; Maia CG; Weitner T; Carballal S; Sampaio RS; Lieb D; Ghazaryan R; Ivanovic-Burmazovic I; Ferrer-Sueta G; Radi R; Reboucas JS; Spasojevic I; Benov L; Batinic-Haberle I Free Radic Biol Med; 2015 Sep; 86():308-21. PubMed ID: 26026699 [TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic action of redox-modulating Mn(III) meso-tetrakis(N-ethylpyridinium-2-yl)porphyrin, MnTE-2-PyP(5+), via suppression of oxidative stress in a mouse model of breast tumor. Rabbani ZN; Spasojevic I; Zhang X; Moeller BJ; Haberle S; Vasquez-Vivar J; Dewhirst MW; Vujaskovic Z; Batinic-Haberle I Free Radic Biol Med; 2009 Oct; 47(7):992-1004. PubMed ID: 19591920 [TBL] [Abstract][Full Text] [Related]
15. New class of potent catalysts of O2.-dismutation. Mn(III) ortho-methoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins. Batinić-Haberle I; Spasojević I; Stevens RD; Hambright P; Neta P; Okado-Matsumoto A; Fridovich I Dalton Trans; 2004 Jun; (11):1696-702. PubMed ID: 15252564 [TBL] [Abstract][Full Text] [Related]
16. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics. Batinic-Haberle I; Rajic Z; Tovmasyan A; Reboucas JS; Ye X; Leong KW; Dewhirst MW; Vujaskovic Z; Benov L; Spasojevic I Free Radic Biol Med; 2011 Sep; 51(5):1035-53. PubMed ID: 21616142 [TBL] [Abstract][Full Text] [Related]
17. The SOD mimic MnTM-2-PyP(5+) reduces hyaluronan degradation-induced inflammation in mouse articular chondrocytes stimulated with Fe (II) plus ascorbate. Campo GM; Avenoso A; D'Ascola A; Scuruchi M; Nastasi G; Micali A; Puzzolo D; Pisani A; Calatroni A; Campo S Int J Biochem Cell Biol; 2013 Aug; 45(8):1610-9. PubMed ID: 23692848 [TBL] [Abstract][Full Text] [Related]
18. Mn-porphyrins as novel molecular magnetic resonance imaging contrast agents. Mouraviev V; Venkatraman TN; Tovmasyan A; Kimura M; Tsivian M; Mouravieva V; Polascik TJ; Wang H; Amrhein TJ; Batinic-Haberle I; Lascola C J Endourol; 2011 Nov; ():1420-4. PubMed ID: 22050509 [TBL] [Abstract][Full Text] [Related]
19. Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant. Mackensen GB; Patel M; Sheng H; Calvi CL; Batinic-Haberle I; Day BJ; Liang LP; Fridovich I; Crapo JD; Pearlstein RD; Warner DS J Neurosci; 2001 Jul; 21(13):4582-92. PubMed ID: 11425886 [TBL] [Abstract][Full Text] [Related]